-
EP3727400
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3727400
| EP3727400 - CRYSTALLINE FORMS OF NICOTINAMIDE RIBOSIDE CHLORIDE [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 22.03.2024 Database last updated on 12.07.2024 | |
| Former | Request for examination was made Status updated on 25.09.2020 | ||
| Former | The international publication has been made Status updated on 29.06.2019 | Most recent event Tooltip | 27.03.2024 | New entry: Despatch of examination report + time limit | Applicant(s) | For all designated states Elysium Health, Inc. 594 Broadway Suite 707 New York, NY 10012 / US | [2020/44] | Inventor(s) | 01 /
MARCOTULLI, Eric 50 Price Street, Apt 6a New York, NY 10012 / US | 02 /
ALMINANA, Dan 50 Franklin Street Apt. 5E New York, NY 10013 / US | 03 /
DELLINGER, Ryan 635 Boxwood Lane Azusa, CA 91702 / US | 04 /
MORRIS, Mark 21 West End Avenue, Apt 2114 New York, NY 10023 / US | [2020/44] | Representative(s) | HGF HGF Limited 1 City Walk Leeds LS11 9DX / GB | [N/P] |
| Former [2020/44] | HGF 1 City Walk Leeds LS11 9DX / GB | Application number, filing date | 18892817.0 | 20.12.2018 | [2020/44] | WO2018US66769 | Priority number, date | US201762609512P | 22.12.2017 Original published format: US 201762609512 P | [2020/44] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019126482 | Date: | 27.06.2019 | Language: | EN | [2019/26] | Type: | A1 Application with search report | No.: | EP3727400 | Date: | 28.10.2020 | Language: | EN | The application published by WIPO in one of the EPO official languages on 27.06.2019 takes the place of the publication of the European patent application. | [2020/44] | Search report(s) | International search report - published on: | US | 27.06.2019 | (Supplementary) European search report - dispatched on: | EP | 21.09.2021 | Classification | IPC: | C07H19/048, C07H1/00, A61P25/00, A61K31/706 | [2021/42] | CPC: |
C07H19/048 (EP);
C07D405/04 (US);
A61P25/00 (EP);
C07H1/00 (EP);
C07B2200/13 (US)
|
| Former IPC [2020/44] | A61K31/706, C07H19/048 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/44] | Title | German: | KRISTALLINE FORMEN VON NICOTINAMID-RIBOSID-CHLORID | [2020/44] | English: | CRYSTALLINE FORMS OF NICOTINAMIDE RIBOSIDE CHLORIDE | [2020/44] | French: | FORMES CRISTALLINES DE CHLORURE DE NICOTINAMIDE RIBOSIDE | [2020/44] | Entry into regional phase | 08.07.2020 | National basic fee paid | 08.07.2020 | Search fee paid | 08.07.2020 | Designation fee(s) paid | 08.07.2020 | Examination fee paid | Examination procedure | 08.07.2020 | Examination requested [2020/44] | 11.04.2022 | Amendment by applicant (claims and/or description) | 26.03.2024 | Despatch of a communication from the examining division (Time limit: M04) | Fees paid | Renewal fee | 14.12.2020 | Renewal fee patent year 03 | 10.11.2021 | Renewal fee patent year 04 | 14.11.2022 | Renewal fee patent year 05 | 15.11.2023 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO2015186068 (GLAXOSMITHKLINE IP NO 2 LTD [GB]) [X] 1,2,4,10-15 * figure 6 *; | [XI]WO2016144660 (W R GRACE & CO -CONN [US]) [X] 1-15 * paragraph [0030]; figure 1; table 1 * * claims 1-24 * [I] 1-15; | [XP]WO2018089830 (UNIV BELFAST [GB], et al) [XP] 1,2,4,10-15 * figures 16, 20 *; | [A] - MINO R CAIRA ED - MONTCHAMP JEAN-LUC, "CRYSTALLINE POLYMORPHISM OF ORGANIC COMPOUNDS", TOPICS IN CURRENT CHEMISTRY; [TOPICS IN CURRENT CHEMISTRY], SPRINGER, BERLIN, DE, vol. 198, doi:10.1007/3-540-69178-2_5, ISSN 0340-1022, (19980101), pages 163 - 208, (19990226), XP001156954 [A] 1-15 * paragraph bridging pages 165-166 * * chapter 3.1 * DOI: http://dx.doi.org/10.1007/3-540-69178-2_5 | International search | [A]WO2016144660 (W R GRACE & CO -CONN [US]) [A] 1-8, 9/1-8 * ; paragraphs [0028]-[0029] *; | [A]US2017204131 (SZCZEPANKIEWICZ BRUCE G [US], et al) [A] 1-8, 9/1-8 * ; figures 2 & 6; paragraph [0019] *; | [A]US2017296564 (DELLINGER RYAN [US], et al) [A] 1-8, 9/1-8 * ; paragraphs [0043]-[0044], [0102]-[0103], 0113, [0116] *; | [A]WO2017218580 (REJUVENATION THERAPEUTICS CORP [US]) [A] 1-8, 9/1-8* ; paragraph [0101] * |